Global Transthyretin Amyloidosis Treatment Market Size, Share, Forecast 2023 – 2033.
The Global Transthyretin Amyloidosis Treatment Market Size is Anticipated to Exceed USD 10.42 Billion by 2033, Growing at a CAGR of 6.56% from 2023 to 2033.Transthyretin Amyloidosis is a rare and progressive disease characterized by the deposition of abnormal proteins such as misTTR in organs and tissue of the body characterized by the alteration in the structure of transthyretin, which leads to the impairment of tetramers formation.